Accelerating FDA Submissions: Understanding New Drug Application Requirements and Developing Biometrics-Focused Strategies to Reduce Costs and Save Time
Tuesday, February 6, 2024 · 10:00 a.m. · Seoul
About This Webinar
Join Amanda Cross, Bioforum’s Chief Operating Officer, to learn how a data-first approach to outsourcing can speed your FDA submission timelines.
Agenda
An overview of the Integrated Summary of Efficacy (ISE) and Integrated Summary of Safety (ISS)
Requirements for FDA data submission packages
ISS/ISE data integration strategies and risk mitigation
Reducing costs and regulatory submission timelines with centralized biometrics
Keys to successfully implementing a biometrics-focused clinical development business model
Amanda has over 25 years of operational and commercial experience in the clinical trial industry at both pharmaceutical companies and CROs, with a particular focus on biometrics. An accomplished leader with a background in statistics, she brings broad experience in data acquisition, refinement, analysis, and reporting, and specializes in optimizing processes, crafting cost-effective solutions, and prioritizing data quality.